Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) shares, rose in value, with the stock price down by -10.27% to the previous day’s close as strong demand from buyers drove the stock to $21.05.
Actively observing the price movement in the recent trading, the stock is buoying the session at $23.46. The PE ratio was 16.08 over 12-month period. Referring to stock’s 52-week performance, its high was $26.16, and the low was $14.47. On the whole, CPRX has fluctuated by -1.64% over the past month.
With the market capitalization of Catalyst Pharmaceuticals Inc currently standing at about $2.57 billion, investors are eagerly awaiting this quarter’s results, scheduled for in June.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 557.23M, with a low estimate of 133.81M and a high estimate of 147.23M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 140.53M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that CPRX’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the PEG ratio is about 1.29, with the price of CPRX currently trading nearly -8.83% and -8.22% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 37.51, while the 7-day volatility ratio is showing 3.36% which for the 30-day chart, stands at 4.32%. Furthermore, Catalyst Pharmaceuticals Inc (CPRX)’s beta value is 0.74, and its average true range (ATR) is 1.06.
A comparison of Catalyst Pharmaceuticals Inc (CPRX) with its peers suggests the former has fared considerably weaker in the market. CPRX showed an intraday change of -10.27% in today’s session so far, and over the past year, it grew by 40.43%%.
Data on historical trading for Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) indicates that the trading volumes over the past 3 months, they’ve averaged 1.26 million. According to company’s latest data on outstanding shares, there are 120.88 million shares outstanding.
Nearly 8.89% of Catalyst Pharmaceuticals Inc’s shares belong to company insiders and institutional investors own 76.70% of the company’s shares. The stock has risen by 0.86% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the CPRX stock heading into the next quarter.
